metQTL
| Dataset | Cohort | Type | Tissue / cell | N | Access |
|---|---|---|---|---|---|
| Knight ADRC brain metabolomics QTL | Knight-ADRC | metQTL | parietal cortex | — | Controlled |
| ROSMAP DLPFC metabolomics QTL | ROSMAP | metQTL | DLPFC | — | Controlled |
Overview
metQTL mapping was performed using the FunGen-xQTL pipeline. Metabolite abundances from untargeted or targeted mass spectrometry underwent log-transformation, batch correction, and covariate adjustment before tensorQTL-based association testing. Fine-mapping was performed using SuSiE-RSS yielding posterior inclusion probabilities (PIPs) and credible sets.
Available Datasets
Brain Tissue
| Dataset | Cohort / Brain Region | AD Knowledge Portal |
|---|---|---|
| ROSMAP DLPFC | ROSMAP dorsolateral prefrontal cortex | syn69670592 |
| Knight ADRC brain | Knight ADRC brain (WashU) | – |
Analyses Performed
Single-Context Fine-mapping
Fine-mapping using SuSiE-RSS per metabolite, providing:
- Posterior inclusion probabilities (PIPs)
- 95% credible sets
- Effect sizes on metabolite abundance
Trans-metQTL Fine-mapping
Genome-wide trans-metQTL analyses identify distant genetic influences on metabolite levels. Trans-metQTL results for ROSMAP DLPFC are provided at ROSMAP DLPFC.
Colocalization
ColocBoost multi-context colocalization identifies shared metabolite QTL signals across cohorts and tissues (syn69670597). AD GWAS–metQTL colocalization results are at syn69865816 and syn69670630.
Data Access
| Resource | AD Knowledge Portal ID |
|---|---|
| Fine-mapping models (metQTL) | syn69670592 |
| Colocalization models | syn69670597 |
| AD–metQTL colocalization results | syn69865816 |
| AD–metQTL colocalization models | syn69670630 |